Implications of recent results of long term multifactorial primary prevention of cardiovascular diseases

Area of Science:

• Cardiovascular Disease Prevention
• Clinical Trial Analysis
• Pharmacological Interventions

Background:

• Multifactorial primary prevention trials for cardiovascular diseases have yielded disappointing results.
• Consistent in-trial prevention benefits have not been achieved, even with improved risk factor levels.
• Long-term follow-up reveals diminished or disappeared differences between treated and control groups.

Purpose of the Study:

• To analyze the efficacy and long-term outcomes of multifactorial primary prevention trials for cardiovascular diseases.
• To investigate the reasons for diminished or increased mortality rates in the post-trial periods.
• To evaluate the potential benefits and harms of pharmacological interventions in cardiovascular disease prevention.

Main Methods:

• Review of multifactorial primary prevention trials for cardiovascular diseases.
• Analysis of in-trial and long-term post-trial follow-up data.
• Examination of risk factor levels, total mortality, and coronary mortality.

Main Results:

• Beneficial in-trial prevention was not consistently obtained.
• Risk factor level differences diminished or disappeared during post-trial follow-up.
• Coronary mortality rates were reduced or increased in the post-trial period for treated groups.

Conclusions:

• Multifactorial prevention strategies require careful selection of pharmacological interventions.
• Further investigation into drug treatments, particularly beta-blockers in mild hypertension, is warranted.
• Pharmacological prevention should be chosen to maximize benefit and minimize harm in cardiovascular disease reduction.